For the year ending 2025-12-31, ARMP has $76,882K in assets. $295,478K in debts. $8,688K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 8,688 | |||
| Prepaid expenses and other current assets | 1,508 | |||
| Other receivables | 472 | |||
| Total current assets | 10,668 | |||
| Restricted cash | 5,390 | |||
| Property and equipment, net | 12,194 | |||
| Operating lease right-of-use asset | 33,911 | |||
| In-process research and development | 10,256 | |||
| Goodwill | 3,490 | |||
| Other assets | 973 | |||
| Total assets | 76,882 | |||
| Accounts payable and accrued liabilities | 1,705 | |||
| Accrued compensation | 2,191 | |||
| Current portion of operating lease liabilities | 4,564 | |||
| Other current liabilities | 487 | |||
| Total current liabilities | 8,947 | |||
| Convertible loan, non-current | 153,860 | |||
| Term debt, non-current | 103,061 | |||
| Operating lease liabilities, net of current portion | 26,533 | |||
| Deferred tax liability | 3,077 | |||
| Total liabilities | 295,478 | |||
| Common stock, 0.01 par value 217,000,000 shares authorized 36,431,444 and 36,183,067 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 364 | |||
| Additional paid-in capital | 282,574 | |||
| Accumulated deficit | -501,534 | |||
| Total stockholders' deficit | -218,596 | |||
| Total liabilities and stockholders' deficit | 76,882 | |||
Armata Pharmaceuticals, Inc. (ARMP)
Armata Pharmaceuticals, Inc. (ARMP)